Claritev Corp
NYSE:CTEV
Claritev Corp
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
Revenue Beat: Claritev reported Q3 revenue of $246 million, up 6.7% year-over-year, marking its best revenue quarter in 12 quarters and beating internal expectations.
Profitability: Adjusted EBITDA was $155.1 million, up 9.5% year-over-year, with EBITDA margin at 63.1%, both ahead of guidance.
Guidance Raised: Management increased full-year revenue growth guidance to 2.8%–3.2% and tightened adjusted EBITDA margin guidance to 62.5%–63%.
Client Renewals: All top 10 clients have been renewed for extended terms, providing stability and visibility into future performance.
Growth Momentum: The company added 5 new logos in the quarter (20 year-to-date), closed $15 million in ACV in Q3, and expects $60 million in new ACV for the year—most of which should convert to revenue in 2026.
International Expansion: First international revenues were recognized this quarter, with new partnerships and product launches in the Middle East.
Strategic Partnerships: Progress is being made embedding solutions with Oracle and growing the payments business, pointing to additional future growth vectors.
